Presentation and binding affinity of equine infectious anemia virus CTL envelope and matrix protein epitopes by an expressed equine classical MHC class I molecule

Journal of Immunology

Volumn 171, Issue 4, 2003, Pages 1984-1993

  McGuire, Travis C ^a   Leib, Steven R ^a   Mealey, Robert H ^a   Fraser, Darrilyn G ^a   Prieur, David J ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP A1 ANTIGEN; COMPLEMENTARY DNA; EPITOPE; IODINE 125; LYMPHOCYTE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MATRIX PROTEIN; PROTEIN ENV RW12; PROTEIN GAG GW12; RETROVIRUS VECTOR; UNCLASSIFIED DRUG;

ALLELE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIGEN BINDING; ANTIGEN PRESENTATION; ARTICLE; BINDING AFFINITY; CELLULAR IMMUNITY; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EQUINE INFECTIOUS ANEMIA VIRUS; GENE EXPRESSION; GENETIC TRANSDUCTION; HAPLOTYPE; HETEROZYGOSITY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNIZATION; LENTIVIRINAE; MAJOR HISTOCOMPATIBILITY COMPLEX; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TARGET CELL; VIRUS ENVELOPE;

EID: 0042635810     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.4.1984     Document Type: Article

References (52)

1. Kono, Y. 1969. Viremia and immunological responses in horses infected with equine infectious anemia virus. Natl. Inst. Anim. Health Q. 9:1.
2. Montelaro, R. C., B. Parekh, A. Orrego, and C. J. Issel. 1984. Antigenic variation during persistent infection by equine infectious anemia virus, a retrovirus. J. Biol. Chem. 259:10539.
3. Perryman, L. E., K. I. O'Rourke, and T. C. McGuire. 1988. Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection. J. Virol. 62:3073.
4. Mealey, R. H., D. G. Fraser, J. L. Oaks, G. H. Cantor. and T. C. McGuire. 2001. Immune reconstitution prevents continuous equine infectious anemia virus replication in an Arabian foal with severe combined immunodeficiency: lessons for control of lentiviruses. Clin. Immunol. 101:237.
5. Kono, Y., K. Kobayashi, and Y. Fukunaga. 1973. Antigenic drift of equine infectious anemia virus in chronically infected horses. Arch. Gesamte Virusforsch. 41:1.
6. Mealey R. H., B. Zhang, S. R. Leib, M. H. Littke. and T. C. McGuire. Moderate to high avidity Rev-specific memory cytotoxic T lymphocytes correlate with control of viral load and clinical disease in horses with equine infectious anemia virus. Virology. In press.
7. Carpenter, S., L. H. Evans, M. Sevoian. and B. Chesebro. 1987. Role of the host immune response in selection of equine infectious anemia variants. J. Virol. 61:3783.
8. + cytotoxic T lymphocytes from horses with equine infectious anemia virus recognize env and gag/PR proteins. J. Virol. 68: 1459.
9. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68:6103.
10. Koup, R. A., J. T. Safrit, Y. Cao, C. A. Andrews. G. McLeod. W. Borkowsky, C. Farthing, and D. D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650.
11. + lymphocyte response in acutely infected rhesus monkeys. J. Virol. 67:1707.
12. Kuroda, M. J., J. E. Schmitz, W. A. Charini, C. E. Nickerson, M. A. Lifton, C. I. Lord, M. A. Forman, and N. L Letvin. 1999. Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys. J. Immunol. 162:5127.
13. + lymphocytes. Science 283:857.
14. Hammond, S. A., S. J. Cook, D. L. Lichtenstein, C. J. Issel, and R. C. Montelaro. 1997. Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process. J. Virol. 71:3840.
15. McGuire, T. C., W. Zhang, M. T. Hines, P. J. Henny, and K. M Byrne. 1997. Frequency of memory cytotoxic T lymphocytes to equine infectious anemia virus proteins in blood from carrier horses. Virology. 238:85.
16. Hammond, S. A., F. Li, B. M. McKeon, S. J. Cook, C. J. Issel, and R. C. Montelaro. 2000. Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus. J. Virol. 74:5968.
17. Kono, Y., K. Hirasawa, Y. Fukunaga, and T. Taniguchi. 1976. Recrudescence of equine infectious anemia by treatment with immunosuppressive drugs. Natl. Inst. Anim. Health Q. 16:8.
18. McGuire, T. C., S. R. Leib, S. M. Lonning, W. Zhang, K. M. Byrne Byme, and R. M. Mealey, 2000. Equine infectious anaemia virus proteins with epitopes most frequently recognized by cytotoxic T lymphocytes from infected horses, J. Gen. Virol. 81:2735.
19. Zhang, W., S. M. Lonning, and T. C. McGuire. 1998. Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection. J. Virol. 72:9612.
20. Barbis. D. P., J. K. Maher, J. Stanek, B. A. Klaunberg, and D. F. Antezak. 1994. Horse cDNA clones encoding two MHC class I genes. Immunogenetics 40:163.
21. Ellis, S. A., A. J, Martin, E. C. Holmes. and W. I. Morrison. 1995. At least four MHC class I genes are transcribed in the horse: phylogenetic analysis suggests an unusual evolutionary history for the MHC in this species. Eur. J. Immunogenet. 22:249.
22. Holmes, E. C., and S. A. Ellis. 1999. Evolutionary history of MHC class I genes in the mammalian order Perissodactyla. J. Mol. Evol. 49:316.
23. Carpenter S., J. M. Baker, S. J. Bacon. T. Hopman, J. Maher, S. A. Ellis, D. F. Antczak. 2001. Molecular and functional characterization of genes encoding horse MHC class I antigens. Immunogenetics 53:802.
24. Bailey, E., E. Marti, D. G. Fraser, D. F. Antczak, and S. Lazary. 2000. Immunogenetics of the horse. In The Genetics of the Horse. A. T. Bowling and A. Ruvinsky, eds. CABI Publishing. New York, p. 123.
25. Bailey, E. 1983. Population studies on the ELA system in American standardbred and thoroughbred mares. Anim. Blood Groups Biochem. Genet. 14:201.
26. Bernoco, D., D. F. Antczak, E. Bailey, K. Bell, R. W. Bull, G. Byrns, G. Guerin, S. Lazary, J. McClure, J. Templeton, et al. 1987. Joint report of the fourth international workshop on lymphocyte alloantigens of the horse. Lexington. Kentucky. 12-22 October, 1985. Anim. Genet. 18:81.
27. Terasaki, P. I., D. Bernoco, M. S. Park, G. Ozturk, and Y. Iwaki. 1978. Microdroplet testing for HLA-A, -B, -C and -D antigens: The Philip Levine Award Lecture. Am. J. Clin. Pathol. 69:103.
28. Albright-Fraser. D. G., R. Reid, V. Gerber, and E. Bailey. 1996. Polymorphism of DRA among equids. Immunogenetics 43:315 [erratum in Immunogenetics 44:487].
29. Fraser, D. G., and E. Bailey. 1998. Polymorphism and multiple loci for the horse DQA gene. Immunogenetics 47:487.
30. Siliciano. R. F., A. D. Keegan, R. Z. Dintzis. H. M. Dintzis. and H. S. Shin. 1985. The interaction of nominal antigen with T cell antigen receptors. I. Specific binding of multivalent nominal antigen to cytolytic T cell clones. J. Immunol. 135:906.
31. Armitage, P. 1971. Statistical Methods in Medical Research. John Wiley & Sons. New York, p. 97.
32. Wyatt, C. R., W. C. Davis, T. C. McGuire. and L. E. Perryman. 1988. T lymphocyte development in horses. I. Characterization of monoclonal antibodies identifying three stages of T lymphocyte differentiation. Vet. Immunol. Immunopathol. 18:3.
33. Yilma, T., L. E. Perryman, and T. C. McGuire. 1982. Deficiency of interferon-gamma but not interferon-β in Arabian foals with combined immunodefiency. J. Immunol. 129:931.
34. Binns, M. M., M. E. Boursnell, I. J. Foulds, and T. D. Brown. 1985. The use of a random priming procedure to generate cDNA libraries of infectious bronchitis virus, a large RNA virus. J. Virol. Methods 11:265.
35. Birnstiel, M. L., M. Busslinger, and K. Strub. 1985. Transcription termination and 3′ processing: the end is in site! Cell 41:349.
36. Gubler, U., and B. J. Hoffman. 1983. A simple and very efficient method for generating cDNA libraries. Gene 25:263.
37. Miller, A. D., and G. J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. BioTechniques 7:980.
38. Lonning, S. M., W. Zhang, S. R. Leib, and T. C. McGuire. 1999. Detection and induction of equine infectious anemia virus-specific cytotoxic T lymphocyte responses using recombinant retroviral vectors. J. Virol. 73:2762.
39. Shimizu, Y. S., D. E. Geraghty, B. H. Koller, H. T. Orr, and R. DeMars. 1988. Transfer and expression of three cloned human non-HLA,B,C class I major histocompatibility complex genes in mutant lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 85:227.
40. McKinney, D. M., A. L. Erickson, C. M. Walker, R. Thimme, F. V. Chisari, J. Sidney, and A. Sette. 2000. Identification of five different Part class I molecules that bind HLA supertype peptides and definition of their peptide binding motifs. J. Immunol. 165:4414.
41. Dzuris, J. L., J. Sidney, E. Appella, R. W. Chesnut, D. I. Watkins, and A. Sette. 2000. Conserved MHC class I peptide binding motif between humans and rhesus macaques. J. Immunol. 164:283.
42. Keogh, E., J. Fikes, S. Southwood, E. Celis, R. Chesnut, and A. Sette. 2001. Identification of new epitopes from four different tumor-associated antigens: recognition of naturally processed epitopes correlates with HLA-A*0201-binding affinity. J. Immunol. 167:787.
43. Tumas, D. B., A. L. Brassfield, A. S. Travenor, M. T. Hines, W. C. Davis, and T. C. McGuire. 1994. Monoclonal antibodies to the equine CD2 T lymphocyte marker, to a pan-granulocyte/monocytes marker and to a unique pan-B lymphocyte marker., Immunobiology 192:48.
44. Davis, W. C., S. Marusic, H. A. Lewin, G. A. Splitter, L. E. Perryman, T. C. McGuire, and J. R. Gorham. 1987. The development and analysis of species specific and cross reactive monoclonal antibodies to leukocyte differentiation antigens and antigens of the major histocompatibility complex for use in the study of the immune system in cattle and other species. Vet. Immunol. Immunopathol. 15:337.
45. Mendenhall W. 1983. Nonparametric statistics. In Introduction to Probability and Statistics. N. Blodgett, ed. Prindle, Weber, and Schmidt, Boston, p. 604.
46. del Guercio, M. F., J. Sidney, G. Hermanson, C. Perez, H. M. Grey, R. T. Kubo, and A. Sette. 1995. Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J. Immunol. 154:685.
47. Allen, T. M., J. Sidney, M. F. del Guercio, R. L. Glickman, G. L. Lensmeyer, D. A. Wiebe, R. DeMars, C. D. Pauza, R. P. Johnson, A. Sette, et al. 1998. Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus. J. Immunol. 160:6062.
48. 131I-labeled human growth hormone of high specific radioactivity. Biochem. J. 89:114.
49. Crawford, T. B., K. J. Wardrop, S. J. Tomquist, E. Reilich, K. M. Meyers, and T. C. McGuire. 1996. A primary production deficit in the thrombocytopenia of equine infectious anemia. J. Virol. 70:7842.
50. Sidney, J., S. Southwood, M. F. del Guercio, H. M, Grey, R. W. Chesnut, R. T. Kubo, and A. Sette. 1996. Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules. J. Immunol. 157:3480.
51. Threlkeld, S. C., P. A. Wentworth, S. A. Kalams, B. M. Wilkes, D. J. Ruhl, E. Keogh, J. Sidney, S. Southwood, B. D. Walker, and A. Sette, 1997. Degenerate and promiscuous recognition by CTL of peptides presented by the MHC class I A3-like superfamily. J. Immunol. 159:1648.
52. Derby, M. A., M. Alexander-Miller, R. Tse, and J. Berzofsky. 2001. High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL. J. Immunol. 166:1690.